PNC Financial Services Group’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $56K | Buy |
16,478
+12,662
| +332% | +$43.1K | ﹤0.01% | 3047 |
|
|
2025
Q1 | $15.3K | Sell |
3,816
-5,034
| -57% | -$20.2K | ﹤0.01% | 3660 |
|
|
2024
Q4 | $57.4K | Buy |
8,850
+4,665
| +111% | +$30.3K | ﹤0.01% | 3023 |
|
|
2024
Q3 | $23.2K | Sell |
4,185
-2,587
| -38% | -$14.3K | ﹤0.01% | 3441 |
|
|
2024
Q2 | $37.8K | Buy |
6,772
+3,024
| +81% | +$16.9K | ﹤0.01% | 3164 |
|
|
2024
Q1 | $25.2K | Sell |
3,748
-2,347
| -39% | -$15.7K | ﹤0.01% | 3331 |
|
|
2023
Q4 | $55.6K | Sell |
6,095
-2,267
| -27% | -$20.7K | ﹤0.01% | 2917 |
|
|
2023
Q3 | $46.2K | Buy |
8,362
+1,150
| +16% | +$6.35K | ﹤0.01% | 3002 |
|
|
2023
Q2 | $61.6K | Buy |
7,212
+6,777
| +1,558% | +$57.9K | ﹤0.01% | 2932 |
|
|
2023
Q1 | $4K | Hold |
435
| – | – | ﹤0.01% | 4107 |
|
|
2022
Q4 | $4.44K | Hold |
435
| – | – | ﹤0.01% | 4026 |
|
|
2022
Q3 | $6K | Hold |
435
| – | – | ﹤0.01% | 3914 |
|
|
2022
Q2 | $5K | Hold |
435
| – | – | ﹤0.01% | 3986 |
|
|
2022
Q1 | $5K | Hold |
435
| – | – | ﹤0.01% | 3989 |
|
|
2021
Q4 | $7K | Buy |
+435
| New | +$7K | ﹤0.01% | 3871 |
|